Notice of Retraction (DOI:10.1016/j.jtcvs.2006.04.055);Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 4, 2006, Pages 861-866

  Ben Gal, Yanai ^a   Mohr, Rephael ^a   Uretzky, Gideon ^a   Medalion, Benjamin ^b   Hendler, Alberto ^c   Hansson, Natalie ^a   Herz, Itzhak ^a   Moshkovitz, Yaron ^c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c ASSUTA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TIROFIBAN;

AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG ELUTING STENT; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INSULIN TREATMENT; INTERMETHOD COMPARISON; INTERNAL MAMMARY ARTERY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

EID: 33748783798     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.07.011     Document Type: Erratum

References (20)

1. Webster M.W., and Scott R.S. What cardiologists need to know about diabetes. Lancet 350 suppl 1 (1997) SE23-SE28
2. Abramov D., Tamariz M.G., Fremes S.F., Gura V., Borger M.A., Christakis G.T., et al. Trends in coronary artery bypass surgery results: a recent, 9-year study. Ann Thorac Surg 70 (2000) 84-90
3. Smith Jr. S.C., Faxon D., Cascio W., Schaff H., Gardner T., Jacobs A., et al. Prevention conference VI: diabetes and cardiovascular disease. Writing group VI: revascularization in diabetic patients. Circulation 105 (2002) e165-e169
4. Barner H.B., Swartz M.I., Mudd J.G., and Tyras D.H. Late patency of the internal mammary artery bypass conduit. Ann Thorac Surg 34 (1982) 408-412
5. Loop F.D., Lytle B.W., and Cosgrove D.M. Influence of internal-mammary-artery-graft on 10-year survival and other cardiac events. N Engl J Med 314 (1986) 1-6
6. BARI Investigators, and The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335 (1996) 217-225
7. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 (2000) 1122-1129
8. Abizaid A., Costa M.A., Centemero M., and Arterial Revascularization Therapy Study Group. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary artery disease. Insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104 (2001) 53-58
9. Sousa J.E., Costa A., Abizaid A., Abizaid A.S., Feres F., Pinto I.M., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195
10. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRollmUS-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109 (2004) 2273-2278
11. Hermiller J.B., Raizner A., Cannon L., and TAXUS-IV Investigators. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus. The TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 12006-12012
12. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002) 8-15
13. Efron B., and Tibshirani R. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1 (1986) 54-77
14. Salm T.J.V., Kip K.E., Jones R.H., Vander Salm T.J., Kip K.E., et al. What constitutes optimal surgical revascularization?. Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 39 (2002) 565-572
15. Sim I., Gupta M., McDonald K., Bourassa M., and Hlatky M.A. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multi-vessel coronary artery disease. Am J Cardiol 76 (1995) 1025-1029
16. Weintraub W.S., Stein R., Kosinski A., Douglas Jr. J.S., Ghazzal Z.M., Jones E.L., et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 31 (1998) 10-19
17. Kimura T., Nosaka H., Yokoi H., Iwabuchi M., and Nobuyoshi M. Serial angiographic follow-up after Palmaz-Schatz stent implantation: comparison with conventional balloon angioplasty. J Am Coll Cardiol 21 (1993) 1557-1563
18. Virmani R., Farb A., Guagliumi G., and Kolodgie F.D. Drug-eluting stents; caution and concerns for long-term outcome. Coron Artery Dis 15 (2004) 313-318
19. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
20. SOS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention (PCI) with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomized, controlled trial. Lancet 360 (2002) 961-962